Patent Term Extension Application for Aveir VR Leadless System, Patent No. 8,295,939 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2023-E-2612

Patent Term Extension Application for Aveir VR Leadless System, Patent No. 8,295,939

Documents

Comments

Description

OPEN

Comment Period OpensJun 26, 2023

Comment Period ClosesAug 16, 2025

Type	Title	Posted	Comments	Status
Other	Letter to U. S. Patent and Trademark Office	Apr 21, 2026	--

CDER

Patent Term Extension Application

Pacesetter Inc.

U.S. Patent No. 8,295,939

Aveir® VR Leadless System

OPEN